Travere Therapeutics(TVTX) - 2024 Q4 - Annual Report

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ☑ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 (State or other jurisdiction of incorporation or organization) (I.R.S. Employer Identification No.) 3611 Valley Centre Drive, Suite 300 San Diego, CA 92130 (Address of Principal Executive Offices) TRAVERE THERAPEUTICS, INC. (Exact Name of Registrant as specified in its Charter) For the Fiscal Year Ended December 31, 2024 Delaware 27-4842691 ...